Results From Lung Transplant Drug Therapy Trial Reveal Expected But Appealing ... MarketWatch (press release) There are currently no therapies which prevent obliterative bronchiolitis after lung transplantation or its alternative, bronchiolitis obliterans syndrome (BOS). The CeMyLungs study looked at 165 lung transplant patients over a three-year period and ... INTERNATIONAL EXPERTS ADDRESS CHALLENGES OF DRUG-RESISTANT INFECTION IN HEART ... |
